Learn more

OHIO MED COLLEGE

Overview
  • Total Patents
    139
About

OHIO MED COLLEGE has a total of 139 patent applications. Its first patent ever was published in 1981. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are MICROCARB INC, JENNER TECHNOLOGIES and RIBOGENE INC.

Patent filings per year

Chart showing OHIO MED COLLEGEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Manning Maurice 33
#2 Willey James C 24
#3 Metzger Dennis W 23
#4 Crawford Erin L 21
#5 Selman Steven H 18
#6 Weaver David A 17
#7 Sawyer Wilbur H 14
#8 Sawyer Wilbur Henderson 14
#9 Arulanandam Bernard P 13
#10 Buchanan Renee M 8

Latest patents

Publication Filing date Title
US2008113903A1 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
WO2005106036A2 Methods and compositions for assaying analytes
US2005260233A1 Attenuated vaccine useful for immunizations against Coccidioides spp. infections
EP1725247A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation
WO2004082463A2 Folate receptor gene modulation for cancer diagnosis and therapy
AU2003223367A1 Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
CA2820020A1 Method and compositions for the diagnosis and treatment of non-small cell lung cancer using gene expression profiles
AU2003222031A8 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples
AU2003243134A1 Modified plasminogen activator inhibitor type-1 and methods based thereon
CA2503094A1 Therapeutic methods for acute myeloid leukemia
US7037895B2 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction
AU2002250285A1 Method for quantitative measurement of gene expression for identifying individuals at risk for bronchogenic carcinoma
AU6543301A Biologically relevant methods for the rapid determination of sterility
US2002106380A1 rSOWgp58 protein and its use as an antigen
EP1058557A1 Enhancement of immunity by intranasal inoculation of il-12
US5985264A IL-12 Stimulation of Neonatal immunity
US6303114B1 IL-12 enhancement of immune responses to T-independent antigens
US5853450A Method for treating bioorganic and wastewater sludges
US5876978A Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction
SG73986A1 Method for treating bioorganic and wastewater sludges